Servier Affaires Médicales

This study tests the safety of combining ivosidenib and azacitidine in adults newly diagnosed with a specific genetic subtype of acute myeloid leukemia (IDH1-mutated) who cannot receive intensive chemotherapy. About 245 participants will receive the drug combination. The goal is …

This study tests a daily pill called ivosidenib in adults with advanced bile duct cancer that has a specific gene change (IDH1 mutation). Participants must have already tried at least one other cancer treatment. The goal is to see if the drug is safe and helps control the cancer.…